In vitro fertilization (IVF) can be a godsend for hopeful parents trying to conceive. 

It’s especially important to patients managing infertility, which is defined as trying to conceive without falling pregnant within 12 months. Infertility is estimated to affect one in six people globally.

However, IVF is an onerous and costly process, partially due to the twice-daily hormonal injections required to mature eggs before retrieval from the body. 

A less-common alternative to IVF is IVM, in vitro maturation, wherein eggs are matured in a lab instead of in the ovaries. However, IVM hasn’t been widely used since its development in the 1990s due to the method’s lower success rate in producing healthy embryos and pregnancies when compared to IVF.

Now, a fertility tech startup is changing that.